a few people working at a table

Press Releases

Ladenburg Thalmann Acts as Lead Manager for Evaxion Biotech A/S (EVAX) in its $30 Million Initial Public Offering

Transaction Information Evaxion Biotech A/S (NASDAQ: EVAX) announced the closing of its initial public offering...

Ladenburg Thalmann Acts as Sole Book-Runner for Helius Medical Technologies, Inc. (HSDT) in its $11 Million Follow-On Offering Priced At Market

Transaction Information Helius Medical Technologies, Inc. (Nasdaq: HSDT) (TSX: HSM) announced the closing of an...

Ladenburg Thalmann Acts as Co-Manager for Krystal Biotech, Inc. (KRYS) in its $143 Million Follow-On Offering

Transaction Information Krystal Biotech, Inc. (NASDAQ: KRYS) announced that it has priced the previously...

Ladenburg Thalmann Acts as Sole Book-Runner for Hancock Jaffe Laboratories, Inc. (HJLI) in its Upsized $41 Million Follow-On Offering

Transaction Information Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) announced that it has successfully...

Ladenburg Thalmann Acts as Co-Manager for Nano-X Imaging Ltd. (NNOX) in its $193.2 Million Secondary Offering

Transaction Information Nano-X Imaging LTD (NASDAQ: NNOX) announced that it has priced the previously announced...

Ladenburg Thalmann Acts as Co-Manager for Bionano Genomics, Inc. (BNGO) in its $101.7 Million Follow-On Offering

Transaction Information Bionano Genomics, Inc. (NASDAQ: BNGO) announced the closing of its previously announced...

Ladenburg Thalmann Acts as Exclusive Placement Agent for Jaguar Health, Inc. (JAGX) in its $15 Million Registered Direct Offering Priced Above-the-Market

Transaction Information Jaguar Health, Inc. (NASDAQ: JAGX) announced it has entered into a securities purchase...

Ladenburg Thalmann Acts as Co-Manager for Bionano Genomics, Inc. (BNGO) in its $230 Million Follow-On Offering

Transaction Information Bionano Genomics, Inc. (NASDAQ: BNGO) announced the closing of its previously announced...

Ladenburg Thalmann Acts as Co-Manager for Lipocine Inc. (LPCN) in its $28.7 Million Follow-On Offering

Transaction Information Lipocine Inc. (NASDAQ: LPCN) announced the closing of an underwritten public offering of...

  • 1
  • ...
  • 11
  • ...
  • 36